Spontaneous T-cell responses against peptides derived from the Taxol resistance–associated gene-3 (TRAG-3) protein in cancer patients-Reference-Cited by-同舟云学术

Spontaneous T-cell responses against peptides derived from the Taxol resistance–associated gene-3 (TRAG-3) protein in cancer patients

Published:2004-10-02 Issue:3 Volume:54 Page:219-228
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Meier Anders,Reker Sine,Svane Inge Marie,Holten-Andersen Lars,Becker Jürgen C.,Søndergaard Ib,Andersen Mads Hald,thor Straten Per

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-004-0578-9.pdf

Reference57 articles.

1. Andersen MH, thor Straten P (2002) Survivin?a universal tumor antigen. Pathol Histopathol 17(2):669?675

2. Andersen MH, Tan L, Sondergaard I, Zeuthen J, Elliott T, Haurum JS (2000) Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens 55(6):519?531

3. Andersen MH, Ostergaard Pedersen L, Becker JC, thor Straten P (2001) Identification of a cytotoxic T lymphocyte response to the apoptose inhibitor protein Survivin in cancer patients. Cancer Res 61:869?872

4. Anthony DD, Lehmann PV (2003) T-cell epitope mapping using the ELISPOT approach. Methods 29(3):260?269

5. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141?196

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma;Nature Medicine;2021-12

2. Improved Natural Killer cell activity and retained anti-tumor CD8+ T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy;Journal of Translational Medicine;2015-06-27

3. A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies;Breast Cancer Research;2011-11-23

4. Therapeutic Cancer Vaccines in Combination with Conventional Therapy;Journal of Biomedicine and Biotechnology;2010

5. CD8 T-Cell Responses Against Cyclin B1;Clinical Cancer Research;2009-11-10